Court Ruling: FDA Can Regulate Stem-Cell Clinics
July 26, 2012 - (Nature) - "The medical director of Regenerative Sciences challenged the FDA, maintaining that the treatment is not subject to FDA regulation because it uses a patient’s own cells. However, a court ruled on Monday that the clinic’s product was a drug and granted the FDA’s request for a permanent injunction against the company. Presumably, the ruling paves the way for further crack-downs. Alternately, it may cause more stem-cell tourism, in which desperate US patients seek treatment abroad, in clinics with even less regulation." Read Full Article
